1.
GTC Biotherapeutics
Offers production of pharmaceutical proteins and monoclonal antibodies in the milk of transgenic animals. Includes information on company, products, ... Show stock quote for GTCB
2.
Monoclonal Antibodies- Monoclonal antibodies, Monoclonal antibody ...
GTC Biotherapeutics (GTC) is a pioneer in the development of monoclonal antibodies and other recombinant proteins expressed transgenically. ...
3.
GTC Biotherapeutics
Offers production of pharmaceutical proteins and monoclonal antibodies in the milk of transgenic animals. Includes information on company, products, ... Show stock quote for GTCB
4.
FIRST PATIENT ENROLLED INTO ATryn® PHASE II STUDY IN DIC INDICATION
FIRST PATIENT ENROLLED INTO ATryn® PHASE II STUDY IN DIC INDICATION FRAMINGHAM, MA - August 6, 2007 -- GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) ...
5.
GTC BIOTHERAPEUTICS COMPLETES BLA SUBMISSION FOR ATryn®
This action date was affirmed by the FDA following preliminary review of the BLA performed in accepting the BLA. ATryn® is GTC’s recombinant form of human ...
6.
GTC BIOTHERAPEUTICS REPORTS SECOND QUARTER 2008 FINANCIAL RESULTS
GTC retains the opportunity to reimburse LFB at a premium for these expenses to restore 50/50 profit sharing under the terms of the existing collaboration ...
7.
ATryn®, recombinant human antithrombin
GTC's lead product, ATryn®, a recombinant form of human antithrombin, also known as ATIII, is at the forefront of transgenic technology for the production ...
8.
GTC Biotherapeutics
Offers production of pharmaceutical proteins and monoclonal antibodies in the milk of transgenic animals. Includes information on company, products, ... Show stock quote for GTCB
9.
GTC Biotherapeutics
Offers production of pharmaceutical proteins and monoclonal antibodies in the milk of transgenic animals. Includes information on company, products, ... Show stock quote for GTCB
10.
Products and Partnering - Plasma Proteins, Monoclonal Antibodies ...
GTC in-licensed the CD137 antibody from the Mayo Clinic and obtained initial SBIR funding in 2004. This product is in the development phase at GTC. ...
